7. Manufacturer recalled the product & found 36
containers of particular lot contaminated with mold
Complaints not always documented
Chemical smell, complaint of molds, stinging for the
cream, labeled (use on newborns & on broken skin)
?
Situation
9. Why every complaint was not documented?
Why investigation was not extended to other lots?
Where is risk assessment of all marketed drugs?
How would you justify the scope of investigation?
How would you justify the sufficiency of CAPA?
Regulatory Concern
11. Material System
1. Are all container, closure and ingredients
from each suppliers qualified?
2. Are their assigned expiration or retest date
appropriate?
3. Are material controls adequate at your end
Regulatory directions
13. Over all system
1. Responsible to investigate deviation?
2. Responsible to investigate atypical events?
3. Responsible to investigate complaints?
Regulatory directions
14. Over all system
1. Responsible to investigate failures?
2. Responsible to investigate OOS?
3. Responsible to investigate OOT?
Regulatory directions
15. CAPA should indicate
1. Improvement in investigation
competencies
2. Improvement in investigating root cause
analysis
3. Improvement in Quality Unit oversight
4. Improvement in evaluating CAPA
effectiveness ….. Etc.
Regulatory directions
17. Documentation System
1. Throughout manufacturing operations
2. Throughout laboratory operations
3. Remediate accuracy of old record
4. Sufficiency & effectiveness Etc ….
Regulatory directions